Biomedcode Hellas SA

Biomedcode Hellas SA is a highly innovative contract research organisation (CRO) offering a diverse array of advanced preclinical evaluation platforms based on a unique collection of spontaneous and induced humanised mouse models that closely recapitulate the pathology and complexity of human inflammatory diseases.

Combining scientific consultation with custom-made solutions, since 2006, Biomedcode has provided preclinical drug evaluation services to more than 110 pharmaceutical and biotech companies worldwide including Europe, the United States and Asia, thus contributing to the successful preclinical evaluation and IND filing of a number of therapeutics.

Biomedcode also maintains a highly active R&D programme that aims to generate and standardise novel humanised disease models to be used as preclinical evaluation platforms as well as advanced tools for the study of disease mechanisms.